Defining Fulminant Clostridioides difficile Infections: Assessing the Utility of Hypotension as a Diagnostic Criterion

• by Hubert C Chua, Taryn A Eubank, Allen Lee, Krishna Rao, Jinhee Jo, Kevin W Garey, Anne J Gonzales-Luna

• January 22, 2025

Advanced Crohn’s Therapies Show Similar Safety

Large claims analysis finds no significant differences in serious infections, blood clots, or major cardiovascular events across biologics and a Janus kinase inhibitor.

• by Doug Brunk

• February 19, 2026

• 2 min

Outcomes of Fecal Microbiota Transplantation for Clostridioides difficile Infection in South Australia

• by Emily C Tucker, Bianca Angelica, Ryan M Mathias, Louisa Edwards, Robert V Bryant, Samuel P Costello

• March 13, 2025

Refining Vancomycin Use in Early CDI

A modified dosing approach could reshape recurrence prevention strategies.

• by Julia Cipriano, MS, CMPP

• March 4, 2026

• 2 min